Dimensional Fund Advisors LP Mustang Bio, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.46 - $0.76 $40,702 - $67,247	-88,483 Reduced 21.12%	330,485 $155,000
Q2 2022 Aug 12, 2022	SELL	$0.58 - $1.13 $131,970 - $257,115	-227,536 Reduced 35.19%	418,968 $245,000
Q1 2022 May 13, 2022	SELL	$0.73 - $1.81 $205,192 - $508,763	-281,085 Reduced 30.3%	646,504 $653,000
Q4 2021 Feb 09, 2022	SELL	$1.66 - $2.64 $216,912 - $344,968	-130,670 Reduced 12.35%	927,589 $1.54 Million
Q3 2021 Nov 12, 2021	SELL	$2.58 - $3.36 $1.08 Million - $1.4 Million	-416,994 Reduced 28.27%	1,058,259 $2.85 Million

Q2 2021 Aug 12, 2021	BUY	$2.7 - $3.81 $1.7 Million - $2.4 Million	630,210 Added 74.58%	1,475,253 $4.9 Million
Q1 2021 May 14, 2021	BUY	$3.02 - $5.16 $2.55 Million - $4.36 Million	845,043 New	845,043 $2.8 Million

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.